Moreover, our laboratory recently reported that nearly 80% of Tpl2−/− mice developed chemically induced skin tumors compared to 16% of wild type mice, providing the first evidence in a de novo cancer model that Tpl2 may serve as a tumor suppressor [19]. The gene discussed is MAP3K8; the disease is skin neoplasm.